{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T04:49:25Z","timestamp":1720241365361},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.atherosclerosis.2017.10.028","type":"journal-article","created":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T16:10:40Z","timestamp":1508775040000},"page":"156-157","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Statin treatment in dialysis patients after acute myocardial infarction improves overall mortality"],"prefix":"10.1016","volume":"267","author":[{"given":"Ertugrul","family":"Ercan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2017.10.028_bib1","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.atherosclerosis.2017.09.018","article-title":"Moderate to high-intensity statin in dialysis patients after acute myocardial infarction: national cohort study in Asia","volume":"267","author":"Chung","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2017.10.028_bib2","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardio- vascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2017.10.028_bib3","series-title":"Dyslipidemia in Chronic Kidney Disease","author":"Tannock","year":"2000"},{"key":"10.1016\/j.atherosclerosis.2017.10.028_bib4","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1053\/ajkd.1998.v32.pm9820470","article-title":"Clinical epidemiology of cardiovascular disease in chro- nic renal disease","volume":"32","author":"Foley","year":"1998","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.atherosclerosis.2017.10.028_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1542-4758.2007.00146.x","article-title":"Modification of cardiovascular risk in hemodialysis patients: an evidence-based review","volume":"11","author":"Johnson","year":"2007","journal-title":"Hemodial. Int."},{"key":"10.1016\/j.atherosclerosis.2017.10.028_bib6","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1177\/1060028013501997","article-title":"Safety and efficacy of statins in patients with end-stage renal disease","volume":"47","author":"Nemerovski","year":"2013","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.atherosclerosis.2017.10.028_bib7","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2017.10.028_bib8","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199811053391902","article-title":"Prevention of cardiovascular events and death with pravastatin in patients with coronary he- art disease and a broad range of initial cholesterol levels. The Long- Term Intervention with Pravas- tatin in Ischaemic Disease (LIPID) Study Group","volume":"339","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2017.10.028_bib9","first-page":"CD004289","article-title":"HMG CoA reductase inhibitors (statins) for dialysis patients","volume":"9","author":"Palmer","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.atherosclerosis.2017.10.028_bib10","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","article-title":"German Diabetes and Dialysis Study Investigators: ator- vastatin in patients with type 2 diabetes mellitus undergoing hemodialysis","volume":"353","author":"Wanner","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2017.10.028_bib11","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa0810177","article-title":"Rosuvastatin and cardiovascular events in patients undergoing hemodialysis","volume":"360","author":"Fellstr\u00f6m","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2017.10.028_bib12","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.ahj.2010.08.012","article-title":"Study of Heart and Renal Pro- tection (SHARP): randomized trial to assess the effects of lowering lowdensity lipoprotein cholesterol among 9,438 patients with chronic kidney disease","volume":"160","year":"2010","journal-title":"Am. Heart J."},{"key":"10.1016\/j.atherosclerosis.2017.10.028_bib13","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial","volume":"377","author":"Baigent","year":"2011","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.10.028_bib14","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/10715762.2016.1241878","article-title":"Oxidized LDL, statin use, morbidity, andmortality in patients receiving maintenance hemodi- alysis","volume":"51","author":"Wagner","year":"2017","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.atherosclerosis.2017.10.028_bib15","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1053\/j.ajkd.2004.09.025","article-title":"HMG-coenzyme a reductase inhibitor use is as- sociated with mortality reduction in hemodialysis patients","volume":"45","author":"Mason","year":"2005","journal-title":"Am. J. Kidney Dis."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2017.10.028_bib16","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1053\/j.semvascsurg.2017.03.001","article-title":"Effect of statins on survival in patients undergoingdialysis access for end-stage renal disease","volume":"29","author":"De Rango","year":"2016","journal-title":"Semin. Vasc. Surg."},{"key":"10.1016\/j.atherosclerosis.2017.10.028_bib17","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1046\/j.1523-1755.2002.00109.x","article-title":"HMG-CoA reductase inhibitors are associated with reduced mortality in ESRD patients","volume":"61","author":"Seliger","year":"2002","journal-title":"Kidney Int."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915017313485?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915017313485?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,26]],"date-time":"2018-08-26T10:58:55Z","timestamp":1535281135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915017313485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":17,"alternative-id":["S0021915017313485"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.10.028","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Statin treatment in dialysis patients after acute myocardial infarction improves overall mortality","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.10.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.09.018","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}